Download Molecular isolation of pathogenic non

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Neonatal infection wikipedia , lookup

Germ theory of disease wikipedia , lookup

Globalization and disease wikipedia , lookup

Infection wikipedia , lookup

Schistosomiasis wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Infection control wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Tuberculosis wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Transcript
1
2
Molecular isolation of pathogenic non-tuberculous mycobacteria in free ranging migratory
wildebeests (Connochaetes taurinus) and cattle of Masai Mara, Kenya.
3
4
Domnic Mijele 1, Isaac Lekolool 1, Francis Gakuya 1, Irmgard Moser 4, Rudovick Kazwala5,
Moses Otiende1, Manfred Tanner 2&3
5
6
7
1
8
9
2
10
3
Friedrich-Loeffler Institut, Südufer 10, 17493 Greifswald-Isle of Riems, Germany.
11
4
Friedrich-Loeffler Institut, Naumburger Strasse 96a, 07743 Jena, Germany.
12
5
Sokoine University of Agriculture P.O Box 3021, Morogoro, Tanzania.
13
Abstract
14
The genus Mycobacterium consists of the members of the Mycobacterium (M.) tuberculosis
15
complex (MTC), non-tuberculous mycobacteria (NTM) and M. leprae. MTC and some NTM
16
organisms cause tuberculosis or tuberculosis-like diseases in humans and other animal species
17
respectively. In Masai Mara conservation area in Kenya, a potential interface between wildlife,
18
livestock and humans is existing due to frequent wildlife and livestock movements and
19
interactions. This study proved the presence of various NTM species in free ranging migratory
20
wildebeests wildebeests (Connochaetes taurinus) and cattle (Bos indicus) through culture,
21
isolation, polymerase chain reaction (PCR) and DNA sequencing techniques using16S rRNA
22
genes followed by hsp65 gene to confirm the results. The study revealed the presence of M.
23
kansasii sub-species VI in 4/60 (6.7%) wildebeests and in 10/89 (11.2%) cattle. One of the
24
wildebeests and 3/89 (3.4%) cattle had M. lentiflavum. M. gordonae was isolated from only one
25
wildebeest while M. intracellulare was detected in 1/89 (1.1%) cattle. No MTC organisms were
26
isolated. The DNA extracts of the isolated mycobacteria were sequence-analysed and published
27
in Genbank with accession numbers assigned. The occurrence of NTM organisms in free ranging
Kenya Wildlife Service, Veterinary Services Department, P.O Box 40241-00100, Nairobi,
Kenya.
Institute for Infectious Diseases and Zoonoses, Department of Veterinary Science, LudwigMaximilians-Universität, Veterinärstr. 13, 80539 München, Germany.
28
migratory wildebeests and cattle may pose a great risk of human infection through consumption
29
of cattle and other livestock or bush-meat products.
30
31
Key words: Wildebeests, M. kansasii, M. lentiflavum, M. intracellulare, hsp65 gene, 16S rRNA
gene.
32
33
Corresponding author: Domnic Mijele; email: [email protected]
34
Background
35
Mycobacterial organisms are the causative agents of tuberculosis and other tuberculosis-like
36
diseases in humans and animals. Mycobacterial infection has a negative impact on livestock
37
production, wildlife conservation and poses an increased risk to humans who may get infected
38
through consumption of uncooked meat or untreated milk from infected animals (Minja et al.,
39
1998). Vice versa, animals may acquire the infection from tuberculosis-infected humans
40
(Alexander et al., 2002). Consumption of infected prey is considered to be the predominant route
41
by which lions in the Kruger National park became infected with M. bovis (Keet, et. al., 2000b).
42
Mycobacterial organisms belonging to the Mycobacterium (M.) tuberculosis complex (MTC) are
43
the causative agents of tuberculosis disease in humans and a broad range of mammalian species.
44
Mycobacterium tuberculosis is the major cause of tuberculosis in humans causing mainly lung
45
disease, while all mammals are susceptible to M. bovis infections, including humans causing
46
mainly extra-pulmonary pathology.
47
Although the causative agent of tuberculosis in birds is normally M. avium, under certain
48
conditions even birds may acquire mammalian tuberculosis. M. avium belongs to the numerous
49
groups of the non-tuberculous mycobacteria (NTM) which are of minor pathogenicity for
50
humans and mammals. Besides these, there are many other emerging NTM species which have
51
been reported to cause disease especially in immunocompromised humans and animals alike.
52
Currently there are over 125 mycobacterial species already identified; both pathogenic and non-
53
pathogenic (Shirin et al., 2010).
54
The Masai Mara ecosystem is characterized by intensive wildlife-livestock-human interactions
55
favourable for disease transmission among different species. The prevalence and distribution of
56
pathogenic and non-pathogenic mycobacterial organisms in wildlife and livestock has not been
57
documented in the ecosystem. This study investigated the presence of both pathogenic and non-
58
pathogenic mycobacteria organisms in wildebeests (Connochaetes taurinus) and cattle (Bos
59
indicus) in this area. The role of NTM in wildebeests and cattle in Masai Mara need to be
60
investigated if they have any impact on public health.
61
Masai Mara ecosystem is situated in Narok County on the south-western part of Kenya. The
62
ecosystem comprises the Masai Mara National Reserve (MMNR) surrounded by several adjacent
63
community-owned wildlife conservancies (figure 1.).
64
65
66
Figure 1. Masai Mara National Reserve in Narok county and wildebeests sampling sites along
the Mara river.
67
MMNR is a government protected area for wildlife conservation which covers an area of
68
approximately 1510 square kilometers and is located on the South-Western part of Kenya along
69
the Kenyan – Tanzanian border between 1°13’ and 1°45’ South and 34°45’ and 35°25’ East. The
70
reserve extends to Serengeti National Park (SNP) in Tanzania where tuberculosis has been
71
reported in lions (figure 1.).
72
The ecosystem has dense populations of wildlife including large mammals such as African
73
elephants, lions, leopards, African buffaloes, black rhinoceros, wildebeests and several antelope
74
species (Mijele et al., 2013). The area is inhabited mainly by Masai pastoral communities
75
keeping large herds of cattle, sheep and goats.
76
There is regular interaction between wildlife, human and livestock within and outside the reserve
77
(Mijele et al., 2013) and frequent cross-border movements of wildlife and livestock between
78
Kenya and Tanzania. MMNR is also known for spectacular annual wildebeests migration
79
between SNP and MMNR in search of adequate pastures (Ogutu et al., 2011). Wildebeests
80
usually drown and die in large numbers while crossing the Mara River during the annual
81
migrations. Frequent animal movements in the area have the potential of enhancing disease
82
transmission among the wildlife-livestock-human populations across the border of Kenya and
83
Tanzania.
84
Methods
85
Wildebeests sampling
86
Postmortem examination was done on 60 wildebeests (Conochaetes taurinus) that drowned in
87
three sites along the Mara River in August 2010. The three sites included Mara bridge (30
88
wildebeests), Serena (20 wildebeests) and Little Governors (10 wildebeests) (figure 1.). The
89
sampling of wildebeests was opportunistic and any wildebeest carcass irrespective of age or sex
90
was retrieved from the river and a detailed postmortem examination conducted to detect
91
granulomas or any other lesions compatible with tuberculosis. Lymph node tissue samples were
92
then collected from retropharyngeal, mediastinal and mesenteric lymph nodes. The samples were
93
labeled and immediately preserved in liquid nitrogen before being transferred to 80°C freezer at
94
the Kenya Wildlife Service laboratory in Nairobi.
95
Cattle sampling
96
Detailed postmortem examination was performed on 89 cattle at Ewaso-Ngiro slaughterhouse
97
within the Masai Mara ecosystem. The selection of cattle for post-mortem was simple random
98
and animals above 2 years of age were targeted. Each carcass was examined for existence of any
99
lesions or pathology related to tuberculosis infection. Tissue samples were collected from
100
retropharyngeal, mediastinal and mesenteric lymph nodes irrespective of whether the animal had
101
lesions or not. The samples were immediately preserved in liquid nitrogen and later transferred
102
to a -80°C freezer at the Kenya Wildlife Service laboratory in Nairobi. All the samples collection
103
was done at the same time in August, 2010.
104
Laboratory analysis
105
Frozen lymph node tissue samples from wildebeest and cattle were transferred to the tuberculosis
106
laboratory at Sokoine University of Agriculture (SUA), Tanzania, where they were processed
107
according to standard methods for isolation of mycobacteria from tissue (Hosek et al., 2006) and
108
cultured on Loewenstein-Jensen (LJ) media for 8 weeks. Colonies that grew on LJ media were
109
stained according to Ziehl-Neelsen and examined for the presence of acid fast bacilli (AFB)
110
under light microscope. From positive cultures, material was taken for polymerase chain reaction
111
(PCR) analysis at SUA and DNA sequence analysis was performed at Friedrich-Loeffler-
112
Institute in Jena, Germany.
113
Colony material was suspended in sterile water, boiled for ten minutes to inactivate the
114
mycobacteria and centrifuged. The supernatant was taken as source of DNA and introduced into
115
mycogenous standard PCR (Kirschner & Boettger 1998). The PCR product was run on an
116
agarose gel with Ethidium Bromide and visualized under UV light. The PCR product band was
117
cut out of the gel and DNA was extracted from agarose gel using QIAquick Gel Extraction kit
118
(Qiagen, Hilden, Germany). The resultant DNA together with sequencing primers was submitted
119
to GATC Biotech Company (Konstanz, Germany) for sequencing.
120
DNA-Sequencing
121
Sequencing of the 16S rRNA gene to identify mycobacterial species was performed according to
122
Kirschner et al. (1998) using primer 271 as sequencing primer. The primers were obtained from
123
Jena Bioscience, Jena, Germany. The sequence data were analyzed at FLI, Jena, Germany, using
124
NCBI Blast software to identify the mycobacteria with the highest match to the sequences.
125
Sequencing of hsp65 gene was performed to differentiate M. kansasii and M. gastri using the
126
primers TB11 (Devallois et al., 1997). Subspecies identity of M. kansasii was determined
127
according to Richter et al., 1999. All the sequence data was published in Gen-bank and provided
128
with accession numbers (table 1a). BioEdit software was used to assess the similarities between
129
the new sequences and the existing sequences in the database.
130
Results
131
There were no lesions or pathology related to tuberculosis infection in all the 60 wildebeests and
132
89 cattle examined. Twenty PCR-positive mycobacterial isolates from 6 wildebeests and 14
133
cattle were sequence-analyzed. Sequencing the 16S rRNA gene yielded DNA stretches of 749 to
134
923 bp in all but one strain where only a length of 311bp was achieved. Sequencing of the hsp65
135
gene yielded DNA stretches of 297 to 421 bp. The maximal identity to the data base entries was
136
99% for the 16S rRNA gene and 99% - 100% for the hsp65 gene (table 2a).
137
Wildebeests results
138
From the 60 wildebeest lymph node samples examined from the Mara River, members of the
139
MTC or M. avium were not isolated. Six out of 60 (10%) wildebeests were found positive for
140
non-tuberculous mycobacteria. Sequences for 16S rRNA gene revealed Mycobacterium
141
kansasii/gastri in retropharyngeal lymph nodes of three (5%) wildebeests and in mediastinal
142
lymph node of one wildebeest (1.7%). One wildebeest (1.6%) had M. lentiflavum in mesenteric
143
lymph node and one (1.6%) had M. gordonae in mediastinal lymph node (table 1a).
144
Further sequencing of the same samples using hsp65 gene confirmed that the four samples which
145
could not be differentiated using 16S rRNA, were all M. kansasii sub-species VI. The results for
146
the other two wildebeests samples remained the same showing M. lentiflavum and M. gordonae
147
respectively (table 1a).
148
Cattle results
149
A variety of non-tuberculous mycobacteria species were isolated from 14 out of 89 (15.7%)
150
cattle lymph node samples examined at the Ewaso Nyiro slaughterhouse. Sequencing of the 16S
151
rRNA gene revealed Mycobacterium kansasii/gastri in ten (11.2%) cattle, Mycobacterium
152
lentiflavum was detected in three (3.4%) cattle and M. intracellulare in one cattle (1.1%) as
153
indicated in (table 1a). Members of the MTC or M. avium were not isolated.
154
Sequencing of the hsp65 gene confirmed that all the M. kansasii/gastri in 10 cattle were M.
155
kansasii sub-species VI. The results for the other four cattle samples remained the same showing
156
M. lentiflavum and M. intracellulare, respectively (table 1a). There was a mixed infection in one
157
cattle Talek01 in which M. lentiflavum was isolated from the mediastinum lymph node and M.
158
kansasii sub-species VI isolated from the retropharyngeal lymph node.
159
160
161
162
163
164
165
166
167
No.
Sample number
Animal
species
FLI
number
Lymph node
Mycobacterial
species (hsp65
gene)
M. kansasii
Accession
numbers
Retropharyngeal
Mycobacterial
species (16S
rRNA gene)
M. kansasii/gastri
1
WB32RETRO
*W/beest
12MA1363
2
WB46MES
W/beest
12MA1366
Mesenteric
M. lentiflavum
M. lentiflavum
KF687953
3
WB48RETRO
4
WB44RETRO
W/beest
12MA1368
Retropharyngeal
M. kansasii/gastri
M. kansasii
KF687952
W/beest
12MA1373
Retropharyngeal
M. kansasii/gastri
M. kansasii
KF687952
5
WB23MED
W/beest
12MA1384
Mediastinal
M. gordonae
M. gordonae
-
6
WB49MED
W/beest
12MA1397
Mediastinal
M. kansasii/gastri
M. kansaii
KF687949
7
M276MES
Cattle
12MA1367
Mesenteric
M. kansasii/gastri
M. kansasii
KF687949
8
M144RETRO
Cattle
12MA1370
Retropharyngeal
M. kansasii/gastri
M. kansasii
KF687952
9
EWB52RETRO
Cattle
12MA1372
Retropharyngeal
M. lentiflavum
M. lentiflavum
KF687953
10
M294RETRO
Cattle
12MA1374
Retropharyngeal
M. kansasii/gastri
M. kansasii
KF687949
11
M309MES
Cattle
12MA1377
Mesenteric
M. lentiflavum
M. lentiflavum
KF687953
12
Talek01MED
Cattle
12MA1391
Mediastinal
M. lentiflavum
M. lentiflavum
KF687953
13
Talek01RETRO
Cattle
12MA1394
Retropharyngeal
M. kansasii
KF687952
14
Sek06 RETRO
Cattle
12MA1395
Retropharyngeal
M. kansasii/
gastri
M. kansasii/gastri
M. kansasii
KF687952
15
M286 RETRO
Cattle
12MA1399
Retropharyngeal
M. kansasii/gastri
M. kansasii
KF687952
16
Sek08 RETRO
Cattle
12MA1400
Retropharyngeal
M. kansasii/gastri
M. kansasii
KF687952
17
M309MES
Cattle
12MA1377
Mesenteric
M. kansasii/gastri
M. kansasii
KF687952
18
VNK01RETRO
Cattle
12MA1403
Retropharyngeal
M. intracellulare
M. intracellulare
KF687950
19
EWB76MES
Cattle
12MA1405
Mesenteric
M. kansasii/gastri
M. kansasii
KF687949
20
M151MED
Cattle
12MA1406
Mediastinal
M. kansasii/gastri
M. kansasii
KF687949
KF687951
Table 1a. Mycobacterial species isolated from lymph node tissue samples of wildebeests and
cattle of Masai Mara. *Wildebeest.
168
169
No.
Animal
species
FLI
number
Mycobacterial
species (16S
rRNA gene)
Mycobacterial species
(hsp65 gene)
New
Genbank
Accession
numbers
Percentage
similarity
KF687951
Closest
existing
accession
numbers in
Genbank
HE575963.1
1
*W/beest
12MA1363
M. kansasii/gastri
M. kansasii ssp VI
2
W/beest
12MA1366
M. lentiflavum
M. lentiflavum
KF687953
KF019694.1
100%
3
W/beest
12MA1368
M. kansasii/gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
4
W/beest
5
W/beest
12MA1373
M. kansasii/gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
12MA1384
M. gordonae
M. gordonae
-
-
-
6
W/beest
12MA1397
M. kansasii/gastri
M. kansasii ssp VI
KF687949
AY550233.1
100%
7
Cattle
12MA1367
M. kansasii/gastri
M. kansasii ssp VI
KF687949
AY550233.1
100%
8
Cattle
12MA1370
M. kansasii/gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
9
Cattle
12MA1372
M. lentiflavum
M. lentiflavum
KF687953
KF019694.1
100%
10
Cattle
12MA1374
M. kansasii/gastri
M. kansasii ssp VI
KF687949
AY550233.1
100%
11
Cattle
12MA1377
M. lentiflavum
M. lentiflavum
KF687953
KF019694.1
100%
12
Cattle
12MA1391
M. lentiflavum
M. lentiflavum
KF687953
KF019694.1
100%
13
Cattle
12MA1394
M. kansasii/ gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
14
Cattle
12MA1395
M. kansasii/gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
15
Cattle
12MA1399
M. kansasii/gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
16
Cattle
12MA1400
M. kansasii/gastri
M. kansasii ssp VI
KF687952
HE575963.1
99%
17
Cattle
12MA1397
M. kansasii/gastri
M. kansasii ssp VI
KF687952
AY550233.1
100%
18
Cattle
12MA1403
M. intracellulare
M. intracellulare
KF687950
NR_074661.1
99%
19
Cattle
12MA1405
M. kansasii/gastri
M. kansasii ssp VI
KF687949
HE575963.1
99%
20
Cattle
12MA1406
M. kansasii/gastri
M. kansasii ssp VI
KF687949
HE575963.1
99%
99%
Table 2a. Percentage of similarities between mycobacterial species isolated from wildebeests
and cattle of Masai Mara and sequences already published in the Genbank. *Wildebeest.
170
171
Discussion
172
The presence of NTM organisms in free-ranging wildebeests and cattle generates a risk for
173
human infection and may be responsible for the presence of human disease compatible with
174
tuberculosis in Masai Mara ecosystem of Kenya.
175
NTM organisms are ubiquitous and are usually recovered from the environment. They can cause
176
disease to humans or animals through respiratory, cutaneous, parenteral and gastrointestinal
177
exposure. The most pathogenic NTM species, M. avium causing tuberculosis in birds and
178
tuberculosis-like disease in humans, especially in immunocompromised persons (e. g. HIV,
179
elderly people) has not been detected. However, other NTM species which have been isolated in
180
the course of this study are also known to cause disease in humans and animals alike.
181
Mycobacterium kansasii is a slow-growing acid-fast bacillius (AFB) and belongs to the NTM
182
group of mycobacteria (Sang et al., 2010) also known as environmental mycobacteria or even
183
called “atypical mycobacteria”. Local water supplies are considered as the major reservoir for M.
184
kansasii, evidence of person-to-person transmission has not been reported. The most common
185
presentation of M. kansasii infection in humans is a chronic bronchopulmonary disease, which
186
manifests typically in adult patients with chronic obstructive pulmonary disease or cystic fibrosis
187
(Sang et al., 2010). In addition, M. kansasii can cause skeletal infections, skin and soft tissue
188
infection, cervical or other lymphadenitis, and disseminated infection (Brown-Elliot et al., 2004).
189
M. kansasii is pathogenic for humans and may cause severe tuberculosis-like disease (Sang et
190
al., 2010). M. kansasii isolation is more common in HIV-positive persons, patients with
191
hematologic malignancy, or patients receiving long-term steroid regimens (Wallace et al., 1997).
192
Infection with M. kansasii requires the same treatment as M. tuberculosis infection (Evans et al.,
193
1996).
194
In wildlife, cattle and other livestock M. kansasii is not pathogenic but it may cause immune
195
reactions and thus interfere with tuberculin skin test or gamma interferon release assay tests.
196
There is a considerable risk of transmission from cattle or wildebeests to humans through
197
consumption of meat or even contact. This is the first time M. kansasii has been isolated from
198
wildebeests of Masai Mara ecosystem.
199
Even though M. kansasii infection has not been reported in Kenya or elsewhere in Africa, it is
200
the second most frequently recognized NTM pathogen and second most frequent cause of
201
disseminated NTM disease, after M. avium complex (MAC), in the Unites States and Japan
202
(Tsukamura et al., 1988; Lillo et al., 1990). In southeast England, M. kansasii is more common
203
than M. avium Complex (Yattes et al., 1997). In South Korea, M. kansasii is the fourth most
204
commonly isolated NTM pathogen, after MAC, M. abscessus-chelonae complex, and M.
205
fortuitum, but its incidence has increased, especially in highly industrialized areas (Yim et al.,
206
2005). Most patients with M. kansasii infection show clinical and radiologic evidence of
207
infection regardless of HIV status.
208
Mycobacterium lentiflavum was recently described as non-tuberculous mycobacterial species
209
(Springer et al., 1996). It is described as a causative agent of cervical lymphadenitis in immuno-
210
compromised human patients and children. M. lentiflavum is resistant to most first line
211
antituberculous drugs. M. lentiflavum is a slow growing acid-fast bacillus (AFB) that has
212
biochemical characteristics identical to those of organisms belonging to the Mycobacterium
213
avium complex (MAC) and mycolic acid and fatty acid chromatography patterns very similar to
214
those of Mycobacterium simiae, so genetic analysis is necessary for conclusive identification
215
(Springer et al., 1996). This organism has been isolated from clinical samples in Italy,
216
Switzerland, Germany, France and Spain (Springer et al., 1996; Tortoli et al., 1997; Niobe et al.,
217
2001; Ibanez et al., 2002) and from sputum samples in Brazil (da Silva Rocha et al., 1999) and
218
Italy (Molteni et al., 2005). Recently, cases of human disease have been reported, including
219
chronic pulmonary disease (Molteni et al., 2005), cervical lymphadenitis (Cabria et al., 2002),
220
liver abscess (Tortoli et al., 2002) and fatal disseminated infection (Ibanez et al., 2002). Our
221
findings are the first evidence of M. lentiflavum infection reported in Kenya. The main reservoir
222
in the environment has not been firmly established, but organisms with M. lentiflavum-like 16S
223
rRNA gene sequences were detected in soil samples from the UK and from France (Mendum et
224
al., 2000) and the species seem to be frequently present in drinking water distribution systems in
225
Finland (Torvinen et al., 2004).
226
Mycobacterium gordonae is the least pathogenic and its isolation is typically regarded as a
227
contaminant (Lessnau et al., 1993). The organism is ubiquitous and it is most commonly isolated
228
from soil and water (Caterina et al., 2009). Clinically significant disease caused by M. gordonae
229
has been reported (Weinberger et al., 1992). Its presence in wildebeest samples could have been
230
due to environmental contamination of the carcasses.
231
Mycobacterium intracellulare is closely related to Mycobacterium avium and similarly causes
232
pulmonary disease in humans. Environmental sources, especially water are the main reservoir for
233
most human infections. Wildebeests and cattle could have acquired M. intracellulare from the
234
environment.
235
The high similarities between mycobacterial organisms in wildebeests and cattle is an indication
236
that there could be cross-transmission of mycobacterial organisms between cattle and
237
wildebeests and possibly to humans or other animals thereby putting human beings at a higher
238
risk of infection. There is a possibility that the isolated mycobacteria exists in the environment
239
from where wildebeests and cattle acquired infection from water or pasture.
240
Authors Contributions
241
DM IL FG RK IM MT MO conceived and designed the experiments for the paper. DM FG IL
242
IM MT performed the experiments. DM IM RK IL analyzed the data. DM RK IL IM contributed
243
reagents, materials and analysis tools. DM IL FG RK IM MT MO wrote the paper. All authors
244
read and approved the final manuscript.
245
Acknowledgement
246
We are grateful for the financial support we received from the German Foundation for Research
247
(DFG). Thanks to all staff at Kenya Wildlife Service, Sokoine University of Agriculture (Faculty
248
of Veterinary Medicine), Friederich Loeffler Institute, Germany who supported this study in one
249
way or another and without whom this work would not have been possible. We acknowledge the
250
significant role of anonymous reviewers who have helped to improve the quality of this work.
251
References
252
253
254
1. Alexander K, Pleydell E, Williams M, Lane E, Nyange J, Michel A Mycobacterium
tuberculosis: an emerging disease of free-ranging wildlife. Emerg Infect Dis.
2002;8:598–601.
255
256
257
2. Brown-Elliott BA, Wallacc RJ, 2004: Infections Caused by Non-tuberculosis
Mycobacteria. In: Mandell GL, Bennett JE, Dolin R, eds. Principle and Practice of
Infectious Disease. 6th ed. Philadelphia: Elsevier 2004: 2909-14.
258
259
260
3. Cabria, F., Torres, M. V., Garcia-Cia, J. I., Dominguez-Garrido, M. N., Esteban, J. &
Jimenez, M. S, 2002: Cervical lymphadenitis caused by Mycobacterium lentiflavum.
Pediatr Infect Dis J 21, 574–575.
261
262
263
264
265
4. Caterina Foti, Vincenza Sforza, Caterina Rizzo, Giovanna De Pascale, Domenico
Bonamonte, Anna Conserva, Antonio Tarantino, Camilla Stella, Stefania Cantore,
Roberto F Grassi, Andrea Ballini, Danila De Vito and Giovanni Angelini, 2009:
Cutaneous manifestations of Mycobacterium gordonae infection described for the first
time in Italy: a case report. Cases Journal 2009, 2:6828 doi:10.4076/1757-1626-2-6828
266
267
268
269
5. da Silva Rocha, A., da Costa Leite, C., Torres, H. M., de Miranda, A. B., Pires Lopes, M.
Q., Degrave, W. M. & Suffys, P. N, 1999: Use of PCR-restriction fragment length
polymorphism analysis of the hsp65 gene for rapid identification of mycobacteria in
Brazil. J Microbiol Methods 37, 223–229
270
271
272
273
6. da Silva Rocha, A., Werneck Barreto, A. M., Dias Campos, C. E., Villas-Boˆ as da Silva,
M., Fonseca, L., Saad, M. H., Degrave, W. M. & Suffys, P. N, 2002: Novel allelic
variants of mycobacteria isolated in Brazil as determined by PCR-restriction enzyme
analysis of hsp65. J Clin Microbiol 40, 4191–4196.
274
275
276
277
7. Devallois, K. S. Goh and N. Rastogi, 1997: Rapid identification of mycobacteria to
species level by PCR-restriction fragment length polymorphism analysis of the hsp65
gene and proposition of an algorithm to differentiate 34 mycobacterial species. J. Clin.
Microbiol. 35: 2969-2973.
278
279
280
8. Evans S A, Colville A, Evans A J, Crisp A J, Johnston I D A, 1996: Pulmonary
Mycobacterium kansasii infection: comparison of the clinical features, treatment and
outcome with pulmonary tuberculosis. Thorax; 51:1248-1252.
281
282
283
9. Hosek J, Svastova P, Moravkova M, Pavlik I, Bartos M, 2006: Methods of mycobacterial
DNA isolation from different biological material: a review. Veterinarni Medicina, 51,
(5): 180–192.
284
285
286
10. Ibanez, R., Serrano Heranz, R., Jimenez-Palop, M., Roman, C., Corteguera, M. &
Jimenez, S, 2002: Disseminated infection caused by slow-growing Mycobacterium
lentiflavum. Eur J Clin Microbiol Infect Dis 21, 691–692.
287
288
289
11. Keet, D.F et, al., (2000b). Tuberculosis in free-ranging lions (Panthera leo) in the
Kruger National Park. Proceedings of the South African Veterinary Association Biennial
Congress, Durban, Kwazulu-Natal, 20-22 September 2000. 10pp.
290
291
292
12. Kirschner P, and Boettger EC, 1998: Species identification of Mycobacteria using rDNA
sequencing, 349-361. In T. Parish and N. G. Stoker (ed.), Methods in molecular
biology, vol. 101. Humana Press, Inc., Totowa, NJ.
293
294
13. Lessnau KD, Milanese S, Talavera W, 1993: Mycobacterium gordonae: a treatable
disease in HIV-positive patients. Chest, 104:1779-1785.
295
296
14. Lillo M, Orengo S, Cernoch P, Harris RL, 1990: Pulmonary and disseminated infection
due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis; 12: 760-7.
297
298
299
15. Mendum, T. A., Chilima, B. Z. & Hirsch, P. R, 2000: The PCR amplification of nontuberculous mycobacterial 16S rRNA sequences from soil. FEMS Microbiol Lett 185,
189–192.
300
301
302
303
16. Mijele D, Obanda V, Omondi P, Soriguer RC, Gakuya F, et al. (2013) Spatio-Temporal
Distribution of Injured Elephants in Masai Mara and the Putative Negative and Positive
Roles
of
the
Local
Community.
PLoS
ONE
8(7):
e71179.
doi:10.1371/journal.pone.0071179.
304
305
306
307
17. Minja, M.G., R. L. Kurwinjila, and N. S. Y. Mdoe, 1998: Occurrence and survival of
Mycobacterium species in fermented milk from traditional cattle herds: A case study of
Usangu plains, Southern highlands, Tanzania. Proceedings of Tanzania Society of
Animal Production 199 -202.
308
309
310
18. Molteni, C., Gazzola, L., Cesari, M., Lombardi, A., Salerno, F., Tortoli, E., Codecasa,
F., Penati, V., Franzetti, F. & Gori, A, 2005: Mycobacterium lentiflavum infection in
immunocompetent patients. Emerg Infect Dis 11, 119–122.
311
312
313
19. Niobe, S. N., Bebear, C. M., Clerc, M., Pellegrin, J.-L., Bebear, C. & Maugein, J, 2001:
Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency
virus-infected patient. J Clin Microbiol 39, 2030–2032.
314
315
316
20. Ogutu JO, Owen-Smith N, Piepho HP, Said MY (2011) Continuing wildlife population
declines and range contraction in the Mara region of Kenya during 1977–2009. J Zool
285: 77–161.
317
318
319
21. Richter E, Niemann S, Rüsch-Gerdes S, Hoffner S, 1999: Identification of
Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques.
J Clin Microbiol.; 37(4):964-70.
320
321
322
323
324
22. Sang Hoon Han, Kyoung Min Kim, Bum Sik Chin, Suk Hoon Choi, Han Sung Lee,
Myung Soo Kim, Su Jin Jeong, Hee Kyoung Choi, Chang Oh Kim, Jun Yong Choi,
Young Goo Song, and June Myung Kim, 2010: Disseminated Mycobacterium kansasii
Infection Associated with Skin Lesions: A Case Report and Comprehensive Review of
the Literature. J Korean Med Sci; 25: 304-8.
325
326
327
23. Shirin A. Mazumder, Anna Hicks, John Norwood, 2010: Mycobacterium gordonae
pulmonary infection in an immunocompetent adult. N Am J Med Sci. 2010 April; 2(4):
205–207.
328
329
330
24. Springer B, Wu WK, Bodmer T, Haase G, Pfyffer GE, Kroppenstedt RM, 1996:
Isolation and characterization of a unique group of slowly growing mycobacteria:
description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol; 34:1100–7.
331
332
333
25. Tortoli, E., Bartoloni, A., Erba, M. L., Levre, E., Lombardi, N., Mantella, A. &
Mecocci, L. 2002: Human infections due to Mycobacterium lentiflavum. J Clin
Microbiol 40, 728–729.
334
335
336
26. Tortoli E, Piersimoni C, Kirschner P, Bartoloni A, Burrini C, Lacchini, 1997:
Characterization of mycobacteria isolates phylogenetically related to but different from
Mycobacterium simiae. J. Clin. Microbiol; 35:697–702.
337
338
339
27. Torvinen, E., Suomalainen, S., Lehtola, M. J., Miettinen, I. T., Zacheus, O., Paulin, L.,
Katila, I. T. & Martikainen, P. J, 2004: Mycobacteria in water and loose deposits of
drinking water distribution systems in Finland. Appl Environ Microbiol 70, 1973–1981.
340
341
342
28. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A, 1988: Studies on the
epidemiology of non-tuberculous mycobacteriosis in Japan. Am Rev Respir Dis; 137:
1280-4.
343
344
345
29. Wallace RJ Jr, Cook JL, Glassroth J, Olivier KN, 1997: Diagnosis and treatment of
disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med; 156: S125.
346
347
348
30. Weinberger, M., S. L. Berg, I. M. Feuerstein, P. A. Pizzo, and F. G. Witebsky, 1992.
Disseminated infection with Mycobacterium gordonae: report of a case and critical
review of the literature. Clin. Infect. Dis. 14:1229–1239.
349
350
351
31. Yates MD, Pozniak A, Uttley AH, Clarke R, Grange JM, 1997: Isolation of
environmental mycobacteria from clinical specimens in south-east England: 1973-1993.
Int J Tuberc Lung Dis; 1: 75-80.
352
353
32. Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS, 2005: Mycobacterium kansasii
pulmonary diseases in Korea. J Korean Med Sci; 20: 957-60.
354
Figure Legends
355
356
Figure 1. Map of Masai Mara National Reserve in Narok county and wildebeests sampling
sites along the Mara river.
357
Tables
358
359
Table 1a. Mycobacterial species isolated from lymph node tissue samples of wildebeests
and cattle of Masai Mara.
360
361
Table 2a. Percentage of similarities between mycobacterial species isolated from
wildebeests and cattle of Masai Mara and sequences already published in the Genbank.